Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Avanti Polar Lipids ALC-0159, PEGylated lipid, 500 mg
Supplier: Avanti Polar Lipids 880155P500MG
ALC-0159 is a PEGylated lipid designed to enhance the stability and biocompatibility of lipid nanoparticle (LNP) drug delivery systems. It significantly improves circulation time and bioavailability for therapeutics by reducing immune recognition, making it a key component in mRNA-based vaccines and other drug delivery applications.
- Enhanced stability and biocompatibility for LNP drug delivery
- Facilitates effective nanoparticle encapsulation and intracellular delivery
- Reduces immune recognition and improves bioavailability
- Essential for mRNA-based vaccines, including COVID-19 formulations
- Applicable in nucleic acid delivery, CRISPR, siRNA, and antisense oligonucleotides
- Soluble in ethanol, DMSO, and specific solvent combinations
- Stored at -20°C and shipped on dry ice
- High purity of over 99% (TLC)
This item is not returnable.
View return policy
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?